研究発表等（講演・口頭発表等） - 織内 昇
-
当科における甲状腺分化癌に対する放射性ヨウ素内用療法
第64回日本甲状腺学会学術集会
-
悪性褐色細胞腫PC12移植マウスにおける123I-MIBGと211At-MABGの体内動態及び線量評価
第61回日本核医学会学術総会
-
正常マウスにおけるフリー 211Atの臓器毒性評価
第61回日本核医学会学術総会
-
褐色細胞腫モデルにおける 211At-MABGの反復投与による腫瘍成長の抑制効果の評価
第61回日本核医学会学術総会
-
分化型甲状腺癌に対するI-131治療の適切な実施のポイント
第61回日本核医学会学術総会
-
正常マウスにおける211At-MABGの臓器毒性と線量評価の検討
第61回日本核医学会学術総会
-
ヒト急性白血病モデルマウスにおける211At-CD33の体内動態
第61回日本核医学会学術総会
-
急性骨髄性白血病における211At標識抗CD82抗体の治療効果
第61回日本核医学会学術総会
-
新規イメージング技術を用いたα線放出核種の組織内局所線量評価の基礎検討
第58回アイソトープ・放射線研究発表会
-
Targeted delivery of 211At with low immunogenic mutant streptavidin–bisiminobiotin pre-targeting system.
Pacifichem2020
-
Biodistribution and dosimetry studies for optimization of pre-targeted radionuclide therapy in 211At labeled modified biotin.
EANM 2020
-
Search for the optimal bis-iminobiotin for the pretargeting strategy using a mutated low immunogenic streptavidin.
EANM 2020
-
Evaluation of therapeutic effect of the targeted alpha therapy using Cupid-211At-labeled Psyche-B pretargeting system in a human gastric cancer cell xenograft.
EANM 2020
-
Prognostic significance of false-positive lymph node on 18F-FDG PET in lung cancer —Clinicopathological study —.
第58回 日本癌治療学会学術集会
-
Preclinical evaluation of cancer stem cell targeted therapy with 211At-labeled anti-CXCR4 antibody.
日本放射線影響学会 第63回大会
-
Stem cells targeted radioimmunotherapy of acute myelogenous leukemia with 211At-labeled anti-CXCR4 monoclonal antibody.
SNMMI 2020
-
Biodistribution of 211At-labeled anti-CXCR4 antibody in tumor xenograft
第59回 日本核医学会学術総会
-
Radiolabeling and biodistribution in the tumor xenograft of 211At-labeled anti-CXCR4 antibody for cancer stem cell targeted alpha-particle therapy
32nd Annual Congress of the European Association of Nuclear Medicine
-
Present status of TAT development at Fukushima Medical University
TAT Workshop in Japan
-
PET-MRIの最前線 ―臨床における有用性と技術的な課題―
第36回日本核医学技術学会関東地方会
-
RI内用療法の原理と実際
第18回日本核医学会春季大会
-
Clinical Application and Development of Theranostics using Novel Targeted Radionuclide Therapy in Japan
The 78th Annual Meeting of the Japan Radiological Society
-
I-131による内用療法の現状と新規治療の発展
第75回 日本放射線技術学会総会学術大会
-
Theranostics in Japan and current status of Fukushima Medical University
Theranostics World Congress 2019
-
α線核種による治療開発とPETの役割
第90回日本核医学会関東甲信越地方会
-
PETによるがん治療の個別化とTheranostics
第31回 日本医学放射線学会関東地方会
-
Targeted Alpha Therapy in Japan - Where we are in 2018 –
EANM’19
-
α線放出核種によるがん治療の進歩と国内における研究開発
日本放射線腫瘍学会第31回学術大会
-
がん治療におけるPETの役割とTheranostics
第31回 九州PET研究会
-
90Y標識抗CD20抗体による悪性リンパ腫の治療 読影・判定について
第35回 イットリウム-90標識抗CD20抗体を用いた放射免疫療法の安全取扱講習会
-
FDG-PET読影の基礎
第12回PET-CT読影実践セミナー
-
頭頚部がん・乳がん
第18回日本核医学会春季大会
-
RI内用療法の原理と実際
第18回日本核医学会春季大会
-
PETによるがん診断とアルファ線による最新の核医学治療
「がんを知り尽くす」シリーズ第6弾
-
α線核種を中心とするがんの核医学治療
放射線安全管理研修会・アイソトープ利用研究会
-
90Y標識抗CD20抗体による悪性リンパ腫の治療 読影・判定について
第34回イットリウム-90標識抗CD20抗体を用いた放射免疫療法の安全取扱講習会
-
甲状腺の画像診断と放射線治療 ―福島医大ではなにができるのかー
第50回日本甲状腺外科学会学術集会
-
Setup of radionuclide therapy ward and initial experience of I-131 therapy in Fukushima Medical University Hospital
第50回日本甲状腺外科学会学術集会
-
がんを治す新しい放射線治療（RI内用療法）の開発 福島県立医大にある加速器とは
第4回国際フォーラム
-
標的RI治療の発展とα線核種の可能性
第58回北日本核医学談話会
-
RI病棟稼動後の現状と課題
第57回日本核医学会学術総会
-
α線放出核種によるがん治療の進歩と放射線治療の中の位置づけ
第57回日本核医学会学術総会
-
Development of Targeted Radionuclide Therapy for Clinical Application
第57回日本核医学会学術総会
-
Monitoring of Ra-223 therapy by FDG-PET/MRI and Bone SPECT in CRPC patients with bone metastases
第57回日本核医学会学術総会
-
Prospects for the development of radiopharmaceuticals at Fukushima Medical University
Phoenix Program The 3rd International Symposium
-
標的RI治療の新展開
第19回 放射線腫瘍学夏季セミナー
-
PET検査室看護師のサイクロトロン導入による被ばく線量の変化
PETサマーセミナー2017
-
α線の臨床応用とXofigoによる去勢抵抗性前立腺癌の治療
第32回福島県核医学研究会
-
RI内用療法の発展と新規開発
第26回宮城県核医学研究会
-
福島県立医科大学におけるα線放出核種による標的RI治療の開発
第２回放射線災害・医科学研究拠点カンファランス
-
The Production of At-211 at Fukushima Medical University
10th International Symposium on Targeted Alpha Therapy
-
FDG-PET読影の基礎
PET-CT読影実践セミナー
-
頭頚部がん・乳がん
第17回日本核医学会春季大会
-
RI内用療法の原理と実際
第17回日本核医学会春季大会
-
福島県立医科大学におけるRI内用療法の実施と新規開発
第54回腫瘍・免疫核医学研究会
-
Production of At-211 by in-house cyclotron and characterization at Fukushima Medical University
第77回日本医学放射線学会総会
-
α線核種による標的治療とふくしま国際医療科学センターにおける新規治療の開発
第59回福岡RIカンファレンス
-
Current Status and Future Prospects of Molecular Imaging and Targeted Radionuclide Therapy in Fukushima Medical University
AFAD 2017
-
Clinical Practice of Nuclear Medicine in Gunma University Hospital.
IAEAがんの放射線医療ワークショップ
-
Development of 76Br-labeled amino acid derivative for PET imaging of tumor
第69回日本癌学会総会
-
Contrast and non-contrast US findings of hepatic metastasis from malignant pheochromocytoma.
European Congress of Radiology (ECR) 2010
-
Improved tumor targeting of 64Cu-labeled streptavidin in colorectal xenografts pretargeted with biotinylated bevacizumab.
World molecular imaging congress(世界分子イメジング学会）
-
Clinical significance of [18F]-α-methyl tyrosine PET as a potential surrogate marker of LAT1 expression for predicting prognosis of non-small cell lung cancer.
ASCO2010
-
Improvement of the dynamic Tc-99m GSA SPECT using 180-degree interpolative reconstruction.
SNM2010
-
Clinical implication of F-18-FDG-PET and MRI for assessing therapeutic effect of anti TNF?antibody in patient with rheumatoid arthritis.
SNM2010
-
CSF phosphorylated tau (p-tau181, p-tau199) in PS1 mutant AD cases.
ICAD2010
-
Clinical Practice of Nuclear Medicine in Gunma University Hospital.
IAEAがんの放射線医療ワークショップ
-
Clinical significance of [18F]-α-methyl tyrosine PET as a potential surrogate marker of LAT1 expression for predicting prognosis of non-small cell lung cancer.
ASCO2010
-
Improvement of the dynamic Tc-99m GSA SPECT using 180-degree interpolative reconstruction.
SNM2010
-
CSF phosphorylated tau (p-tau181, p-tau199) in PS1 mutant AD cases.
ICAD2010
-
Development of 76Br-labeled amino acid derivative for PET imaging of tumor
第69回日本癌学会総会
-
新規放射性核種『ルテチウム-177』標識抗体によるがん治療
第14回日本がん免疫学会総会
-
がんのPETイメージング薬剤としての76Br標識アミノ酸の有用性
第5回日本分子イメージング学会総会
-
Contrast and non-contrast US findings of hepatic metastasis from malignant pheochromocytoma.
European Congress of Radiology (ECR) 2010
-
PDG-PETで集積亢進を示した副腎オンコサイトーマの一例.
第437回日本医学放射線学会関東地方会
-
Improved tumor targeting of 64Cu-labeled streptavidin in colorectal xenografts pretargeted with biotinylated bevacizumab.
World molecular imaging congress(世界分子イメジング学会）
-
RIの医学利用の現状と期待されるRI.「RI国内製造にむけての開発研究」
第1回シンポジウム（日本原子力研究開発機構）
-
FDG-PETにおける集積が結核の活動性を反映していたと推察される1剖検例
第435回日本医学放射線学会関東地方会
-
64Cu-DOTA-オクトレオタイドの有用性の検討
第49回日本核医学会総会
-
64Cu labeled PET for the vascular endothelial growth factor in colon cancer
第49回日本核医学会学術総会
-
Near infrared fluorescence imaging of angiogenesis
第49回日本核医学会学術総会
-
Initial evaluation of [F-18] alfa-methyl tyrosine PET for differential diaguosis of pancreatic lesions
ＳＮＭ2009
-
頭蓋骨軟部腫瘤性病変の画像所見と鑑別
第68回日本医学放射線学会学術発表会
-
Clinicopathological features of metastasis of liver from rectalcarcinoid determined by F-18-FDG uptake and expression of glucose transporter I and hexokinase Ⅱ
EANM 2009
-
原発性骨病変の診断にFDG-PETが有用であった成人発症ランゲルハンス細胞組織球症の2例
第７１回日本核医学会関東甲信越地方会
-
内照射療法が奏効した悪性褐色細胞腫の１例
第７１回日本核医学会関東甲信越地方会
-
Bevacizumab based nearinfrared fluorescence imaging of VEGF in colon cancer.
4th Annual meeting of Japanese Society of Molecular imaging (日本分子イメジング学会）
-
Imaging and biodistribution of 64Cu labeled trastuzumab in Her2/neu overexpressing non-small cell lung cancer xenografts.
20th Asia Pacific cancer conference
-
Avastin based in vivo imaging of vascular endothelial growth factor in colon cancer.
第4回 日本分子イメージング学会 総会・学術集会
-
Radioimmunotherapy of B-NHL with 90Y-labeled Anti-CD20 Monoclonal Antibody．The 7th Annual Meeting of Japanese Society of Medical Oncology
第7回日本臨床腫瘍学
-
頭頸部がん・乳がん．
第9回日本核医学会春季セミナー
-
[F-18]-α-methyl tyrosine (18F-FMT) Non-FDG PET probe in oncology．
IAEA/RCA regional training course on RTC on Advance Clinical Application of PET
-
Current status of nuclear medicine in Japan．
IAEA
-
非小細胞肺癌の診断と予後評価における18F-FAMT PETの有用性. シンポジウム6 「次世代の腫瘍トレーサ」
第49回日本核医学会学術総会
-
核医学治療－90Y標識抗CD20抗体によるB細胞悪性リンパ腫の治療を中心に－.
第47回日本癌治療学会総会
-
Expression of L-type amino acid transporter 1 determined by [18F] fluoro alpha-methyl tyrosine (18F-FMT) PET correlates with the prognosis of patients with resectable stage I-III non-small cell lung cancer ．
56th SNM Annual Meeting 第56回米国核医学会
-
新規放射性核種『ルテチウム-177』標識抗体によるがん治療の基礎的検討
第4回高崎量子応用研究シンポジウム
-
Near infrared fluorescence imaging of angiogenesis
第49回日本核医学会学術総会
-
64Cu labeled PET for the vascular endothelial growth factor in colon cancer
第49回日本核医学会学術総会
-
Differential Diagnosis and Assessment of Prognosis in Malignant Pleural Mesothelioma with 18F-FDG PET.
RSNA 2009
-
Assessment of therapeutic response and prognosis in malignant pleural mesotheliona with 18F-FDG-PET.
22th Annual Congress of the EANM
-
Clinicopathological features of metastasis of liver from rectalcarcinoid determined by F-18-FDG uptake and expression of glucose transporter I and hexokinase Ⅱ
EANM 2009
-
Initial evaluation of [F-18] alfa-methyl tyrosine PET for differential diaguosis of pancreatic lesions
ＳＮＭ2009
-
Bevacizumab based nearinfrared fluorescence imaging of VEGF in colon cancer.
4th Annual meeting of Japanese Society of Molecular imaging (日本分子イメジング学会）
-
Imaging and biodistribution of 64Cu labeled trastuzumab in Her2/neu overexpressing non-small cell lung cancer xenografts.
20th Asia Pacific cancer conference
-
Radioimmuno PET imaging of vascular endothelial growth factor in colon cancer.
22th Annual Congress of the European Association of Nuclear Medicine
-
Targeted imaging with 64Cu trastuzumab PET in non small cell lung cancer.
International Conference on Radiopharmaceutical Therapy (ICRT-2009)
-
Preliminary evaluation of L-[F-18]-alpha-methyl tyrosine PET/CT in the differential diagnosis of maxillofacial tumor.
56th SNM Annual Meeting
-
Advantage of LMEGP collimator in the brain SPECT image acquisition with I-123 labeled radiophamaceutical;Preliminary evaluation of the image quality using one day rest and rest method.
22th Annual Congress of the EANM
-
Can whole body bone SPECT (MIP) with shorter waiting time (90 minutes) replace conventional whole body bone scan without losing lesion detectability?
22th Annual Congress of the EANM
-
Can serum catecholamine at 1 week after I-131 MIBG therapy predict response in malignant pheochromocytoma?
22th Annual Congress of the EANM
-
Synthesis and evaluation of 76BrDG for tumor diagnosis using microPET in mice.
22th Annual Congress of the EANM
-
Clinical usefulness of FDG-PET for the assessment of primary peritoneal cancer.
22th Annual Congress of the EANM
-
Avastin based in vivo imaging of vascular endothelial growth factor in colon cancer.
第4回 日本分子イメージング学会 総会・学術集会
-
[F-18]-α-methyl tyrosine (18F-FMT) Non-FDG PET probe in oncology．
IAEA/RCA regional training course on RTC on Advance Clinical Application of PET
-
Current status of nuclear medicine in Japan．
IAEA
-
Expression of L-type amino acid transporter 1 determined by [18F] fluoro alpha-methyl tyrosine (18F-FMT) PET correlates with the prognosis of patients with resectable stage I-III non-small cell lung cancer ．
56th SNM Annual Meeting 第56回米国核医学会
-
Preliminary evaluation of L-[F-18]-alpha-methyl tyrosine PET/CT in the differential diagnosis of maxillofacial tumor.
56th SNM Annual Meeting
-
Advantage of LMEGP collimator in the brain SPECT image acquisition with I-123 labeled radiophamaceutical;Preliminary evaluation of the image quality using one day rest and rest method.
22th Annual Congress of the EANM
-
Synthesis and evaluation of 76BrDG for tumor diagnosis using microPET in mice.
22th Annual Congress of the EANM
-
Clinical usefulness of FDG-PET for the assessment of primary peritoneal cancer.
22th Annual Congress of the EANM
-
Assessment of therapeutic response and prognosis in malignant pleural mesotheliona with 18F-FDG-PET.
22th Annual Congress of the EANM
-
Differential Diagnosis and Assessment of Prognosis in Malignant Pleural Mesothelioma with 18F-FDG PET.
RSNA 2009
-
頭蓋骨腫瘤性病変の画像所見と鑑別.
第68回日本医学放射線学会
-
Radioimmuno PET imaging of vascular endothelial growth factor in colon cancer.
22th Annual Congress of the European Association of Nuclear Medicine
-
Targeted imaging with 64Cu trastuzumab PET in non small cell lung cancer.
International Conference on Radiopharmaceutical Therapy (ICRT-2009)
-
L-[F-18]-alpha-methyl tyrosine PET as a metabolic marker for the diagnosis of pulmonary adenocarcinoma.
World Cancer Congress 2008.
-
PET imaging and biodistribution of 64Cu labeled monoclonal antibody.
The Third Takasaki Advanced Radiation Research Symposium
-
Imaging and localization of 64Cu labeled trastuzumab in Her2/neu overexpressing non-small lung cancer xenografts.
The Fourth International Symposium on Biomedical Research Using Accelerator Technology
-
18F-FDG PETを用いた非小細胞肺癌のゲフィチニブによる治療効果の早期評価ならびに予後予測
第46回日本癌治療学会総会
-
Prognostic implication of LAT1 expression determined by [F-18]-α-methyl tyrosine PET in non-small cell lung cancer
67th Annual Meeting of the Japan Cancer Association 第67回 日本癌学会総会
-
非小細胞肺癌における[F-18]-α-methyl tyrosine PETと予後．
第48回日本核医学会学術総会
-
悪性リンパ腫の早期の治療効果と予後予測における18F-FDG-PETの有用性．
第48回日本核医学会学術総会
-
In-111 Zevalinシンチグラフィによる適応決定の実際．
第43回 腫瘍免疫核医学研究会
-
非小細胞肺癌に対するゲフィチニブの早期治療効果予測におけるFDG-PETの有用性．
第67回日本医学放射線学会総会
-
PETによる悪性腫瘍の治療効果判定 18F-FDG PETの現状と新しいトレーサーの有用性．
第46回癌治療学会総会
-
悪性リンパ腫の診断と治療 －核医学の役割－ 111In標識抗CD20抗体のイメージング． シンポジウム１
第48回 日本核医学会学術総会
-
肺癌の診断と予後評価における18F-FMT PETの有用性．
PETサマーセミナー2008
-
悪性褐色細胞腫に対するI-131-MIBG治療．シンポジウム 4 笑顔の見られる核医学－アイソトープ治療－ RI内用療法の現状と最近の話題
第67回 日本医学放射線学会総会
-
Y-90標識抗体による悪性リンパ腫の放射免疫治療．
第44回日本医学放射線学会秋季臨床大会
-
腫瘍核医学（本邦における最近のトピック）専門医教育セミナー
第8回 日本核医学会春季大会
-
Current status of nuclear medicine in oncology.
South Asia Conference of Radiology 2008
-
Radio-activated compound produced associated with the operation of small medical cyclotron.
Annual congress of the European Association of Nuclear Medicine,
-
Potential utility of 64Cu labeled monoclonal antibody for imaging with PET.
Annual congress of the European Association of Nuclear Medicine,
-
Clinical usefulness of FDG-PET/CT in the evaluation of Langerhans cell histiocytosis occurred in pelvic bone.
Annual congress of the European Association of Nuclear Medicine
-
Comparison of gated myocardial perfusion single-photon emission tomography with contrast enhanced MRI for detection of myocardial damage in dilated cardiomyopathy.
Annual congress of the European Association of Nuclear Medicine,
-
Multimodality Molecular Imaging of Lymphoma with Combined PET and Optical Modalities.
2008 Japanese Society of Nuclear Medicine （日本核医学会）.
-
Development of a radiolabeled peptide derivative targeting matrix metalloproteinase-2, for imaging tumors.
第67回癌学会総会
-
Correlation between PET and spectral fluorescence for imaging lymphoma using dual labeled probe.
Japanese society for molecular imaging(日本分子イメジング学会）
-
64Cu labeled antibody for tumor imaging with PET.
12th Annual meeting of society of fundamental cancer immunology（日本免疫学会総会）
-
Multimodality molecular imaging of CD20 expressing lymphoma with combined nuclear and optical modalities.
2008 world molecular imaging congress (世界分子イメジング学会）
-
PET imaging and biodistribution of 64Cu labeled monoclonal antibody.
The Third Takasaki Advanced Radiation Research Symposium
-
Imaging and localization of 64Cu labeled trastuzumab in Her2/neu overexpressing non-small lung cancer xenografts.
The Fourth International Symposium on Biomedical Research Using Accelerator Technology
-
Clinicopathological study with F-18-FDG PET for assessing metabolic activity of arthritis in patients with rheumatoid arthritis.
RSNA2008
-
Varying 18F-FDG uptake and clinicopathological presentation in Hepatocellular Carcinoma and Cholangiocellular Carcinoma: Case Presentation.
South Asian conference on Radiology(南アジアの放射線会）
-
Multimodality Molecular Imaging of Lymphoma with Combined PET and Optical Modalities.
2008 Japanese Society of Nuclear Medicine （日本核医学会）.
-
Differential Diagnosis of Mass-forming Pancreatic Diseases with [F-18] Alpha-methyl Tyrosine PET.
RSNA2008
-
Prognostic implication of LAT1 expression determined by [F-18]-α-methyl tyrosine PET in non-small cell lung cancer
67th Annual Meeting of the Japan Cancer Association 第67回 日本癌学会総会
-
Current status of nuclear medicine in oncology.
South Asia Conference of Radiology 2008
-
Radio-activated compound produced associated with the operation of small medical cyclotron.
Annual congress of the European Association of Nuclear Medicine,
-
Potential utility of 64Cu labeled monoclonal antibody for imaging with PET.
Annual congress of the European Association of Nuclear Medicine,
-
Clinical usefulness of FDG-PET/CT in the evaluation of Langerhans cell histiocytosis occurred in pelvic bone.
Annual congress of the European Association of Nuclear Medicine
-
Comparison of gated myocardial perfusion single-photon emission tomography with contrast enhanced MRI for detection of myocardial damage in dilated cardiomyopathy.
Annual congress of the European Association of Nuclear Medicine,
-
L-[F-18]-alpha-methyl tyrosine PET as a metabolic marker for the diagnosis of pulmonary adenocarcinoma.
World Cancer Congress 2008.
-
PET/CT装置における三次元逐次近似画像再構成方法の臨床的有用性の評価（Evaluation of the usefulness of new 3D iterative image reconstruction method in the diagnostic reading of clinical PET/CT image
第48回日本核医学会総会
-
Differential Diagnosis of Mass-forming Pancreatic Diseases with [F-18] Alpha-methyl Tyrosine PET.
RSNA2008
-
Clinicopathological study with F-18-FDG PET for assessing metabolic activity of arthritis in patients with rheumatoid arthritis.
RSNA2008
-
Development of a radiolabeled peptide derivative targeting matrix metalloproteinase-2, for imaging tumors.
第67回癌学会総会
-
64Cu labeled antibody for tumor imaging with PET.
12th Annual meeting of society of fundamental cancer immunology（日本免疫学会総会）
-
Varying 18F-FDG uptake and clinicopathological presentation in Hepatocellular Carcinoma and Cholangiocellular Carcinoma: Case Presentation.
South Asian conference on Radiology(南アジアの放射線会）
-
Correlation between PET and spectral fluorescence for imaging lymphoma using dual labeled probe.
Japanese society for molecular imaging(日本分子イメジング学会）
-
Multimodality molecular imaging of CD20 expressing lymphoma with combined nuclear and optical modalities.
2008 world molecular imaging congress (世界分子イメジング学会）
-
Early response evaluation of gefitinib with F-18-FDG PET in patients with non-small cwll lung cancer
Early response evaluation of gefitinib with F-18-FDG PET in patients with non-small cwll lung cancer
-
Targeting FZD10, a cell-surface protein, for radioimmunotherapy of synovial sarcoma.
55th SNM annual meeting
-
Evaluation of dispersion of SUV obtained by different PET system; preliminary cylinder phantom study.
EANM 2007
-
Comparative study of FDG-PET and I-123 MIBG scan in the evaluation of therapeutic effect of malignant pheochromocytoma treated bya I-131 MIBG therapy.
EANM 2007
-
Age-related changes of serotonintransporter density measured by 11C-DASB in healthy volunteers.
20th Annual Congress of EANM 2005
-
Biodistribution, Safety, and Pharmacokinetics of Humanized Monoclonal Antibody huA33 in Patients with Gastric Carcinoma Determined by 131I-labeled huA33.
第20回欧州核医学会年次総会
-
Comparative study of FDG-PET and I-123 MIBG scan in the evaluation of therapeutic effect of malignant pheochromocytoma treated bya I-131 MIBG therapy.
EANM 2007
-
骨シンチグラフィとの比較による血中ICTPの骨転移診断における臨床的有用性の検討．
第47回日本核医学会学術総会
-
造影MRI検査と心筋血流シンチグラフィを施行した拡張型心筋症の所見．
第47回日本核医学会学術総会
-
頭頚部腫瘍のfunctional imaging：ブドウ糖代謝の組織血流の関係について．
第431回日本医学放射線学会関東地方会
-
90Y標識ヒト抗CEA抗体によるがん治療の基礎的検討
第7回放射性医薬品・画像診断研究会
-
Targeting FZD10, a cell-surface protein, for radioimmunotherapy of synovial sarcoma.
55th SNM annual meeting
-
イットリウム-90標識ヒト抗CEA抗体によるがん治療の基礎的検討
第11回 基盤的癌免疫研究会総会
-
滑膜肉腫の治療を目的としたFZD10を標的分子とする90Y標識抗体開発
第41回 腫瘍・免疫核医学研究会
-
悪性褐色細胞腫の診断と治療
第11回心血管内分泌代謝学会学術総会 クリニカルアワーⅡ
-
Biodistribution, Safety, and Pharmacokinetics of Humanized Monoclonal Antibody huA33 in Patients with Gastric Carcinoma Determined by 131I-labeled huA33.
第20回欧州核医学会年次総会
-
Usefulness of FDG-PET for the evaluation of maxillofacial tumors: Comparison to conventional studies with CT/MRI.
53th Annual Meeting of the Society of Nuclear Medicine
-
Design and management of PET facility (PET scanner, hot laboratory and clinical cyclotron)
IAEA-RCA Regional Training Course on “PET Applications for Oncologists, Radiation Oncologists and Haematologists” for RAS/6/042 2006.
-
Diagnosis of primary tumor in patients with cancer of unknown primary using F-18-FDG PET.
European Association of Nuclear Medicine Congress.
-
FDG-PET and immunohistochemical staining to differentiate hepatocellular carcinoma and cholangiocellular carcinoma: Representative case presentation.
9th Congress of the World Federation of Nuclear Medicine & Biology
-
滑膜肉腫の治療を目的としたFZD10を標的分子とする90Y標識抗体開発
第４６回 日本核医学会学術総会
-
Glucose transporters expression in hepatocellular carcinoma compared with FDG-PET
Annual Congress of the Europian Association of Nuclear Medicine
-
Preclinical evaluation of 67Cu-labeled monoclonal antibody for cancer therapy.
53th Annual Meeting of the Society of Nuclear Medicine
-
Clinical study using L-3-[18F] fluoro-methyltyrosine (FAMT) and 18F-FDG PET for maxillofacial tumor: Comparative immunohistopathological analysis with cellular proliferation (Ki-67) and amino-acid transporter expression (LAT-1).
53th Annual Meeting of the Society of Nuclear Medicine
-
非密封アイソトープによる治療 90Y標識抗体による悪性リンパ腫．
第43回 アイソトープ・放射線研究発表会
-
Diagnosis of carcinoma of unknown primary with F-18-FDG PET.
9th Congress of World Federation of Nuclear Medicine & Biology
-
FDG-PET and immunohistochemical staining to differentiate hepatocellular carcinoma and cholangiocellular carcinoma: Representative case presentation.
9th Congress of the World Federation of Nuclear Medicine & Biology
-
Glucose transporters expression in hepatocellular carcinoma compared with FDG-PET
Annual Congress of the Europian Association of Nuclear Medicine
-
Expression of Glucose Transporter in hepatocellular carcinoma compared with FDG-PET
65th annual meeting of Japanese Radiological Society,
-
Design and management of PET facility (PET scanner, hot laboratory and clinical cyclotron)
IAEA-RCA Regional Training Course on “PET Applications for Oncologists, Radiation Oncologists and Haematologists” for RAS/6/042 2006.
-
Diagnosis of primary tumor in patients with cancer of unknown primary using F-18-FDG PET.
European Association of Nuclear Medicine Congress.
-
Preclinical evaluation of 67Cu-labeled monoclonal antibody for cancer therapy.
53th Annual Meeting of the Society of Nuclear Medicine
-
Clinical study using L-3-[18F] fluoro-methyltyrosine (FAMT) and 18F-FDG PET for maxillofacial tumor: Comparative immunohistopathological analysis with cellular proliferation (Ki-67) and amino-acid transporter expression (LAT-1).
53th Annual Meeting of the Society of Nuclear Medicine
-
Usefulness of FDG-PET for the evaluation of maxillofacial tumors: Comparison to conventional studies with CT/MRI.
53th Annual Meeting of the Society of Nuclear Medicine
-
Diagnosis of carcinoma of unknown primary with F-18-FDG PET.
9th Congress of World Federation of Nuclear Medicine & Biology
-
Expression of Glucose Transporter in hepatocellular carcinoma compared with FDG-PET
65th annual meeting of Japanese Radiological Society,
-
Preclinical evaluation of 90Y-labeled anti-CD20 monoclonal antibody, NuB2, for cancer therapy.
52th Annual Meeting of the Society of Nuclear Medicine
-
Correlation between FDG-PET and alpha fetoprotein in the evaluation of recurrent hepatocellular carcinoma treated with radiofrequency ablation
45th Annual meeting of Japanese society of Nuclear medicine (JSNM )
-
Cellular proliferation and amino-acid transporter expression of maxillofacial tumor evaluated with L-3-[18F]fluoro-alpha-methyltyrosine (FAMT) and 18F-FDG PET.
Australian and New Zealand Society of Nuclear Medicine 35th Annual Scientific Meeting 2005
-
Use of FDG-PET in the evaluation of recurrent hepatocellular carcinoma treated with radiofrequency ablation.
Australian and New Zealand Society of Nuclear Medicine 35th Annual Scientific Meeting 2005
-
Preclinical Evaluation of Radiolabeled Anti-CD20 Monoclonal Antibody, NuB2, for Cancer Therapy.
EANM'05 - Annual Congress of the European Assocation of Nuclear Medicine
-
A preliminary of the usefulness of L-3-[18F]fluoro-alpha-methyltyrosine (FAMT) PET in the evaluation of malignancy of maxillofacial tumor; Comparative study with 18F-FDG PET and immunohistochemical analysis of cellular proliferation (Ki-67) and amino-a・・・
EANM'05 - Annual Congress of the European Assocation of Nuclear Medicine
-
Clinical study using L-3-[18F]fluoro-alpha-methyltyrosine (FAMT) and 18F-FDG PET for maxillofacial tumor with analysis on cellular proliferation (Ki-67) and amino-acid transporter expression (LAT-1).
The Second International Symposium on Biomedical Research Using Accelerator Technology
-
悪性褐色細胞腫のI-131 MIBG治療中にFDG-PETで見られる褐色脂肪組織への集積とノルアドレナリン刺激との関係．
第64回日本癌学会総会
-
ヒト型モノクローナル抗体huA33を用いた胃癌治療のPhase I 臨床研究
第64回日本癌学会
-
Cellular proliferation and amino-acid transporter expression of maxillofacial tumor evaluated with L-3[18F]fluoro-alpha-methyltyrosine and 18F-FDG PET.
The First International Symposium on Biomedical Research Using Accelerator Technology
-
放射性同位元素のがん治療への応用．
第64回日本医学放射線学会総会
-
悪性褐色細胞腫のI-131 MIBG治療中にFDG-PETで見られる褐色脂肪組織への集積とノルアドレナリン刺激との関係．
第64回日本医学放射線学会総会
-
FDG PET を用いた投球動作における肩関節周囲筋の評価
第78回日本整形外科学会学術総会
-
大腿骨頸部骨折患者における FDG PET を用いた痴呆の評価
第78回日本整形外科学会学術総会
-
Use of FDG-PET in the evaluation of recurrent hepatocellular carcinoma treated with radiofrequency ablation.
Australian and New Zealand Society of Nuclear Medicine 35th Annual Scientific Meeting 2005
-
Preclinical Evaluation of Radiolabeled Anti-CD20 Monoclonal Antibody, NuB2, for Cancer Therapy.
EANM'05 - Annual Congress of the European Assocation of Nuclear Medicine
-
A preliminary of the usefulness of L-3-[18F]fluoro-alpha-methyltyrosine (FAMT) PET in the evaluation of malignancy of maxillofacial tumor; Comparative study with 18F-FDG PET and immunohistochemical analysis of cellular proliferation (Ki-67) and amino-a・・・
EANM'05 - Annual Congress of the European Assocation of Nuclear Medicine
-
Relation between FDG uptake and immunohistochemistry of gastrointestinal stromal tumor.
51th Annual Meeting of the Society of Nuclear Medicine
-
Noninvasive determination of regional myocardial perfusion and perfusion reverse with first-pass MR imaging
Progress in Radiology 2004
-
がん患者のうつ状態に関する脳機能画像学的並びに精神内分泌学的解析
第63回日本癌学会総会
-
[18F] Fluoro-α-methyl-tyrosine による腫瘍の診断．
第36回 腫瘍・免疫核医学研究会
-
通電療法(ECT)を施行した感情障害患者の神経内分泌機能と脳局所糖代謝変化部位の検討－薬物療法を施行した患者群との比較－
第23回 躁うつ病の薬理・生化学的研究懇話会
-
頭頸部腫瘍に対するPETの臨床的有用性．
第28回日本頭頸部腫瘍学会
-
再発食道癌に対するPET検査の診断精度について
第63回日本癌学会学術総会
-
MR myocardial perfusion for the assessment of microcirculation
第６3回日本医学放射線学会学術発表会
-
MDCTを用いた心筋血流量の定量的評価の検討
第６２回日本医学放射線学会学術発表会
-
Principle and clinical application of positron emission tomography using [18F] 2-fluoro-2-deoxy-D-glucose.
2nd Annual General Meeting of Asian Regional Cooperative Council for Nuclear Medicine.
-
ラジオアイソトープ結合抗体を用いた悪性腫瘍の診断と治療．
第62回日本癌学会 カッティングエッジフォーラム 「抗体作成技術の進歩と抗体療法の現状」
-
Gastrointestinal stromal tumorに対するFDG-PETの有用性の検討．
第43回日本核医学会総会
-
マキシマム・スロープ法を用いたMRI心筋血流評価(冠血流予備能の測定)
第６２回日本医学放射線学会学術発表会
-
画像診断－FDG-PETの有用性．
第15回日本放射線腫瘍学会学術大会 ワークショップ「悪性リンパ腫最近の知見」
-
TypeⅢ mutant EGFRを特異的に認識する99mTc標識３C10モノクロナル抗体によるヌードマウス脳内移植モデルでの画像診断．
第61回日本癌学会総会
-
ヒト型モノクローナル抗体huA33のPhaseⅠ研究における生検標本と手術切除標本における抗原発現の検討と問題点
第61回日本癌学会総会
-
骨シンチグラフィ上陰性でFDG-PETを施行した肺癌骨転移の1例
第53回日本核医学会関東甲信越地方会
-
Clinical significance of L-[3-18F]-a-methyl tyrosine PET studies in intracranial and intrathoracic tumor: A comparative study with 18F-FDG PET.
47th Annual Meeting of the Society of Nuclear Medicine
-
肺腫瘍に対する術前診断としてのF-18FDG-PETとC11choline-PETの意義．
第41回日本肺癌学会総会
-
L-[3-18F]-α-methyl tyrosine (FMT) PETによる縦隔リンパ節の鑑別診断．
第40回日本核医学会総会
-
ストロンチウム（89Sr）を用いる転移性骨腫瘍の疼痛に対する新しい治療
日本核医学技術学会 関東地方会
-
放射線ヨード（131I）標識抗体CD20抗体を用いるB細胞性悪性リンパ腫移植SCIDマウスの放射免疫治療
癌学会
-
Localization of radioiodinated anti-human pulmonary surfactant-associated proteins mAb in human pulmonary adenocarcinoma xenografted on nude mice.
12nd Annual Congress of the European Association of Nuclear Medicine
-
Radioimmunotherapy of SCID mice bearing human B-cell lymphoma using I-131 labeled anti-CD20 monoclonal antibody.
12nd Annual Congress of the European Association of Nuclear Medicine
-
Antigen-antibody dependent difference in the biodistribution and pharmacokinetics of Tc-99m-labeled monoclonal antibodies between animal models and patients with tumors.
12nd Annual Congress of the European Association of Nuclear Medicine
-
Detection of malignant tumors with whole-body PET using F-18 a-methyl tyrosine: Comparison with whole-body FDG PET.
46th Annual Meeting of the Society of Nuclear Medicine
-
放射性ストロンチウム（89Sr）による転移性骨腫瘍の疼痛緩和療法．
第58回日本癌学会総会
-
SPECT収集における散乱線補正
第２５回群馬核医学研究会
-
The evaluation of soft tissue lesions using fluorine-18-FDG PET.
11th Annual Congress of the European Association of Nuclear Medicine
-
18F-methyltyrosine PETによる胸部良悪性病変の鑑別
第25回腫瘍・免疫核医学研究会
-
Synthesis and biodistribution studies of rhenium-186 complex of 3-amino-1-hydroxyp ropylidene-1,1-bisphosphonic acid (APD) in mice.
45th Annual Meeting of the Society of Nuclear Medicine
-
Comarative study of PET and quantitative digital radiography (QDR) in detecting effects of aging and diet on bone metabolism of guinea pig.
11th Annual Congress of the European Association of Nuclear Medicine
-
The evaluation of soft tissue lesions using fluorine-18-FDG PET.
11th Annual Congress of the European Association of Nuclear Medicine
-
18F-fluoro-α-methyl tyrosineによる肺癌ならびに良性胸部疾患のPET．
第38回日本核医学会総会.
-
99mTc-MIBI／201Tlシンチグラフィによるマウス腫瘍のタキソール抵抗性の評価．
第57回日本癌学会総会
-
プリズム2000XP－PCDの使用経験
第２６回群馬核医学研究会
-
Tc-99m標識ヒト化抗体の臨床応用．
第53回日本癌学会総会
-
99mTc標識抗NCAキメラ抗体の基礎的検討．
第33回日本核医学会総会
-
Prediction of outcome of cardiomyopathy using 123I-MIBG myocardial SPECT.
40th Annual Meeting of the Society of Nuclear Medicine
-
99mTc標識抗NCAモノクローナル抗体の基礎的検討．
第32回日本核医学会総会
-
Gliomaにおける201Tl塩化タリウムの取り込みと糖代謝．
第31回日本核医学会総会
-
Evaluation of Tl-201 brain SPECT in patients with glioma: Relation to histologic grade, prognosis and proliferative activity of tumor cells.
Society of North America 77th Scientific Assembly and Annual Meeting
-
脊髄小脳変性症における99mTc-Ethyl Cysteinate Dimer (ECD) SPECT－PETによるCBFとの比較－
第30回日本核医学会総会
-
A system development and clinical trial for computer aided diagnosis of Tl-201 myocardial SPECT.
2nd Annual Congress of the European Association of Nuclear Medicine
-
Clinical usefulness of SPECT using Tl-201 and IMP in patient with brain tumor-Comparison with PET study using F-18 FDG.
4th Asia and Oceania congress of Nuclear Medicine